Physician profile
Mitra Patel
NPI 1538622501
$614.75
in general payments reported to CMS, 2019-2025
13 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $69.98 · 2023: $22.79 · 2024: $227 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Abiomed | $95.88 | 2024-2025 | Impella |
| Medtronic, INC. | $90.47 | 2022-2024 | Corevalve Evolut R |
| Boston Scientific Corporation | $49.79 | 2025 | General - Vascular Access |
| Inari Medical, INC. | $37.57 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bracco Diagnostics INC. | $31.51 | 2024 | |
| Pfizer INC. | $27.76 | 2022 | |
| Edwards Lifesciences Corporation | $26.91 | 2022 | |
| Novartis Pharmaceuticals Corporation | $26.27 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.00 | 2024 | |
| Biotronik INC. | $22.79 | 2023 | |
| Stryker Corporation | $21.63 | 2025 | Flowtriever |
| Viatris Specialty LLC | $18.17 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitra Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.